Eppendorf and BioLabs Expand Their Partnership to Promote Biotech Innovations
Biotech startups in Munich gain access to laboratory equipment, technical expertise, and a networked innovation community
Eppendorf and BioLabs, a global innovation infrastructure company that creates the physical and collaborative conditions for life sciences research worldwide, announced the expansion of their partnership to the new BioLabs | TUM location in Munich. This expands a partnership that already includes BioLabs locations in the U.S., France, and Germany. Through this partnership, entrepreneurs in the biotechnology and life sciences sectors gain access to laboratory equipment, technical expertise, and a connected innovation community.
Opening of BioLabs | TUM. From left to right: Dr. Johannes Fruehauf, CEO of BioLabs; Dr. Max Pöhlmann, Site Director, BioLabs TUM; Dr. Floris Engelhardt, CEO/CSO and co-founder of Kano Therapeutics; Dr. Philipp Gerbert, CEO of TUM Venture Labs; Johanna Michielin, Regional Director, BioLabs Europe
Eppendorf
As part of the partnership, Eppendorf will serve as a Gold Sponsor of BioLabs | TUM in Munich. The collaboration underscores their shared commitment to strengthening the life sciences ecosystem: BioLabs provides the physical, collaborative, and operational framework in which startups can develop their businesses. Eppendorf contributes laboratory technologies and expertise that support research and growth in day-to-day laboratory work. This includes the provision of instruments and associated software, training programs for employees, and equipment maintenance. In addition, Eppendorf will host lectures and conferences. For companies based at BioLabs | TUM, the location offers opportunities for workshops, on-site events, and other networking formats.
BioLabs | TUM is located within Munich’s dynamic innovation ecosystem and welcomed its first resident companies earlier this summer. The facility offers shared and private lab spaces, offices, operational support, and access to a community of entrepreneurs, mentors, investors, and industry partners. The goal is to support the continued growth of the regional life sciences ecosystem in conjunction with the overarching TUM Venture Labs.
“Expanding our collaboration with BioLabs to the new Munich location enables us to make our equipment and expertise even more directly accessible to a new generation of biotech companies,” said Axel Ziemke, Vice President Central Area EMEA, Eppendorf Vertrieb Deutschland GmbH. “The partnership combines practical support for laboratories with opportunities for direct exchange between Eppendorf and the companies shaping the future of the life sciences.”
“The partnership between BioLabs and Eppendorf has been in place for more than ten years. We are therefore very proud to now expand this long-standing collaboration to Munich,” said Johannes Fruehauf, CEO and founder of BioLabs. “Our mission is to support entrepreneurs and innovative scientists in bringing groundbreaking ideas to life. We are convinced that Eppendorf shares this commitment. We look forward to working with Eppendorf to support the next generation of life sciences companies in Munich and to further expanding our collaboration within this important ecosystem.”
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Other news from the department business & finance
These products might interest you
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.